EGFR and neoplasm: The independent risk factors of overall complications were male sex (odds ratio [OR], 5.064; 95% confidence interval [CI]: 1.865, 13.749; p = 0.001), tumor size ≤ 2 cm (OR, 3.367; 95% CI: 1.298, 8.735; p = 0.013), EGFR-TKIs combined with chemotherapy (OR, 3.633; 95% CI: 1.199, 11.006; p = 0.023), and transfissural approach (OR, 7.583; 95% CI: 1.272, 45.209; p =0.026).